Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
cancer diagnostics
deals
2
×
life sciences
merck
2
×
national blog main
new york blog main
raleigh-durham blog main
san diego blog main
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
10x genomics
abbvie
adverum biotechnologies
albert bourla
alzheimer's disease
amgen
amicus therapeutics
arvinas
astellas pharma
batten disease
bayer
becton dickinson
biogen
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
breast cancer
brian stuglik
cancer
cancer immunotherapy
casimir trials
celenex
christine mcsherry
chuck schumer
clinial trials
crispr therapeutics
What
company
2
×
acquisitions
adding
aims
albert
biggest
bio
bourla
ceo
crispr
deal
decisions
diagnostic
diagnostics
drug
expand
fold
future
help
imports
make
maker
maps
measured
nanostring
patients
pfizer
pfizer’s
physicians
reach
revenue
roundup
technology
tests
today
treatment
veracyte
world’s
Language
unknown
unset
Current search:
company
×
deals
×
merck
×
@xconomy.com
4 years ago
Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
